Last Updated: August 27, 2026
Retrieved from live GLP-1 Reviews review pages.
Selecting a GLP-1 provider in 2026 has evolved beyond simply finding a prescription. The market has bifurcated into two distinct philosophies: high-touch metabolic resets and efficient, value-driven clinical access. Calibrate and Mochi Health represent the pinnacle of these respective paths, both earning "Top Tier" status in our directory, but serving fundamentally different patient needs.
While Calibrate focuses on a 12-month "Metabolic Reset" backed by intensive 1:1 coaching and insurance navigation, Mochi Health has built its reputation on price transparency and industry-leading access to compounded GLP-1 medications. In this comparison, we break down the clinical rigor, true monthly costs, and patient experiences of both platforms.
At a Glance: Key Differences
| Feature | Calibrate | Mochi Health |
|---|---|---|
| GLP-1.Reviews Score | 4.7 / 5.0 (Top Tier) | 4.8 / 5.0 (Top Tier) |
| Monthly Membership | $199/mo | $79/mo standard (1-month tier $39) |
| Medication Type | Brand-Name Only (Insurance-dependent) | Brand-Name & Compounded |
| Compounded Pricing | N/A | $99 (Semaglutide) / $199 (Tirzepatide) |
| All-In Monthly Cost | $199/mo + medication separate | $178 (Semaglutide) / $278 (Tirzepatide) |
| Lab Testing | Included in Membership | Not Included |
| Care Model | 1:1 video coaching + dietitian + labs | Live video provider visit model + dietitian + bariatric specialists |
| Best For | Behavioral change & insurance coverage | Value-conscious buyers & self-pay |
1. Pricing and True Monthly Cost (August 2026)
The most immediate differentiator between Calibrate and Mochi Health is the cost structure. Based on the live GLP-1 Reviews review pages, the gap in standard monthly membership fees alone reaches $120 per month, or $1,440 per year before medication costs are added.
Calibrate Pricing
Calibrate operates as a premium metabolic health program. Its $199/month membership includes:
- Access to Calibrate clinicians for GLP-1 prescribing.
- 1:1 video coaching.
- Lab testing.
- Dietitian access.
- A structured year-long metabolic reset program.
Critical Note: Medication costs are separate from the membership fee. Calibrate exclusively prescribes brand-name medications like Ozempic, Wegovy, Zepbound, and Mounjaro. Medication cost depends on insurance coverage and the pharmacy used. Calibrate is designed for patients who want a brand-only program and are prepared for an insurance-dependent path.
Mochi Health Pricing
Mochi Health is widely considered the industry leader for "Top Tier" value. Its pricing currently includes:
- $79/month standard membership, with $39 listed as the separate 1-month plan tier in the intake walkthrough (versus 3/6/12-month tiers)
- Dietitian access
- Bariatric specialist support
Unlike Calibrate, Mochi offers a flat-rate compounded medication program:
- Compounded Semaglutide: $99/month
- Compounded Tirzepatide: $199/month
All-in Comparison: A self-pay patient on semaglutide would pay $178/month total with Mochi Health, while a patient on compounded tirzepatide would pay $278/month total. At Calibrate, the monthly program fee is $199, but medication remains separate and depends on insurance approval and pharmacy pricing.
2. Clinical Rigor and Drug Availability
Both providers are evaluated under our weighted scoring methodology, which prioritizes clinical oversight, trust, support, and pharmacy standards.
Calibrate: The "Metabolic Reset" Philosophy
Calibrate (4.7 / 5.0 (Top Tier)) is built around a year-long metabolic reset model rather than quick prescription access.
- Drugs Available: Ozempic, Wegovy, Zepbound, Mounjaro.
- Medication Model: Brand-name only. Calibrate does not offer compounded GLP-1 medications.
- Program Structure: Lab testing, dietitian access, and 1:1 video coaching are included.
- Clinical Highlight: Calibrate’s live review page currently shows Clinical Quality 5.0 and Support 5.0, reinforcing its high-touch, insurance-dependent care model.
Mochi Health: Transparency in Compounding
Mochi Health (4.8 / 5.0 (Top Tier)) stands out for price transparency and broad access to compounded GLP-1 care.
- Drugs Available: Compounded semaglutide, compounded tirzepatide, and brand-name GLP-1 options listed on the live review page.
- Compounding Detail: Mochi says it works with state-licensed compounding pharmacies; it names none and does not offer a certificate of analysis.
- Clinical Highlight: Mochi includes dietitian access and bariatric specialists in its care model and uses a live video provider visit model for prescribing.
3. Patient Flow and Onboarding
The "Speed to Start" varies significantly between these two providers, reflecting their differing program goals.
The Calibrate Journey (12-Month Commitment)
- The Intake: Calibrate uses a more moderate onboarding process tied to its structured metabolic program.
- The Lab Work: Lab testing is included and helps establish a baseline before treatment planning.
- Clinician Visit: A video visit is used to review results and discuss brand-name GLP-1 options.
- Insurance Navigation: Because Calibrate is brand-only, the process remains closely tied to insurance coverage and pharmacy fulfillment.
- Coaching Kick-off: Patients move into a year-long metabolic reset program with 1:1 video coaching and dietitian support.
The Mochi Health Journey (Access-First)
- The Intake: A 14-screen intake process captures medical history and requires payment upfront.
- Live Video Visit: You schedule a live video visit with a licensed provider.
- Medication Selection: You decide between trying for brand-name access or using Mochi’s compounded semaglutide or tirzepatide programs.
- Fulfillment: Compounded medications are fulfilled through state-licensed compounding pharmacies, though specific partners are not publicly named on the live review page.
4. Who Should Choose Calibrate?
Calibrate is a "Top Tier" provider, but it is not for everyone. It is a premium health investment.
Best for Patients Who:
- Have Commercial Insurance: If your employer-sponsored plan covers Wegovy or Zepbound with a small co-pay, Calibrate’s $199/month fee is justified by their insurance navigation and intensive coaching.
- Value 1:1 Human Interaction: Calibrate’s bi-weekly video coaching is the most "high-touch" behavioral support in the industry.
- Want a Lifestyle Overhaul: If you are frustrated by yo-yo dieting and want a curriculum that teaches you how to eat, sleep, and move for your unique biology, Calibrate’s framework is unmatched.
- Insist on Brand-Only: If you are uncomfortable with compounded medications and only want FDA-approved brand pens, Calibrate’s clinical team will exclusively support that path.
5. Who Should Choose Mochi Health?
Mochi Health currently holds one of the highest scores in our directory (4.8 / 5.0) because it combines broad access, lower entry pricing, and a transparent compounded medication path.
Best for Patients Who:
- Are Paying Out-of-Pocket: If you do not have insurance coverage for weight loss meds, Mochi’s $178/month all-in semaglutide price and $278/month all-in tirzepatide price are much easier to budget for than a brand-only program with separate medication costs.
- Prioritize Speed: Mochi’s onboarding is faster than Calibrate’s, largely because it does not include labs as part of the membership and uses a live video provider visit model with a direct compounded option.
- Want Dietitian Access: Mochi includes dietitian access and bariatric specialists, which can matter for patients who want obesity-focused support alongside medication management.
- Need Nationwide Access: Mochi is available in all 50 states, making it one of the broadest-access GLP-1 telehealth options in the directory.
6. Summary of Scores: How They Compare
According to our 2026 Global GLP-1 Industry Statistics, provider integrity and pharmacy transparency have become the top priorities for consumers.
Here is how these two stack up based on the live review pages and our standardized scoring framework:
- Overall Tier: Both providers are currently listed as Top Tier under the GLP-1 Reviews methodology.
- Calibrate: 4.7 / 5.0, with Clinical Quality 5.0 and Support 5.0 on the live review page.
- Mochi Health: 4.8 / 5.0, with pricing transparency and nationwide access as major differentiators on the live review page.
- Care Model Difference: Calibrate is a structured, insurance-dependent, brand-only program; Mochi is a lower-cost access model that includes compounded options.
Ultimately, Calibrate is a lifestyle program that uses medication, while Mochi Health is a clinical platform that provides medication with lifestyle support.
7. Reputation, Trust, and Complaints
Trust signals matter in GLP-1 care, but they do not all measure the same thing. In this comparison, both companies earn Top Tier status on GLP-1 Reviews, yet their trust profiles look different when you zoom in on public reputation markers and operating model.
For Calibrate, the strongest trust indicator on the live review page is its Trustpilot 4.6 rating across 1,200+ reviews. That signal fits the broader positioning of the company: a premium, structured, year-long metabolic health program that emphasizes coaching, lab testing, and insurance-based access to brand-name medications. In practical terms, that reputation profile may matter most to patients who are less focused on the cheapest possible monthly access and more focused on guided support, accountability, and a formal program structure. Calibrate’s trust signals also align with the fact that it does not offer compounded medications, which may appeal to patients who want a brand-only path.
Mochi Health presents a different trust picture. Its live review page notes broad all-50-states availability. It does not offer a certificate of analysis for its compounded medications and names no pharmacy, so the quality-control questions many self-pay buyers have cannot be checked against a document.
The practical takeaway is that Calibrate’s trust profile is stronger if you value traditional reputation markers and a structured insurance-dependent program, while Mochi’s transparency strength is more specific to compounded medication access and documentation. Neither public rating system replaces a conversation with a licensed clinician. Use these signals as screening tools, not as substitutes for clinical judgment.
8. Clinical Monitoring: Labs, Follow-Up, and Care Cadence
One of the clearest differences between these providers is how they handle monitoring over time. Calibrate builds monitoring into the program itself, while Mochi separates access from some of the testing logistics.
Calibrate’s $199/month membership includes lab testing, dietitian access, and 1:1 video coaching inside a structured year-long metabolic reset. That matters because it creates a more defined care cadence from day one. Patients are not just paying for the prescription pathway; they are paying for a program that includes baseline assessment and follow-up support as part of the recurring fee. In practice, that means bloodwork is part of the care model rather than an extra step the patient has to coordinate independently. For someone who wants a guided framework with predictable check-ins, that structure can reduce friction.
Mochi Health uses a different model. Its live review page shows no lab testing included, but it does include dietitian access, bariatric specialists, and a live video provider visit model. Practically, that means a patient should confirm early whether bloodwork is recommended, when it should be completed, and where it can be arranged if it is not built into the plan. That does not automatically make Mochi less clinically useful. It simply means the patient may have more responsibility for coordinating labs outside the membership.
The follow-up cadence also differs. Calibrate is built around a more formal rhythm, including its bi-weekly coaching structure, which supports behavior change over a longer period. Mochi’s live video model is more access-oriented and can feel more flexible for patients who want medication management without enrolling in a year-long lifestyle program. If you want labs and follow-up built into one recurring package, Calibrate is easier to understand. If you want lower-cost access and are comfortable managing some logistics separately, Mochi may feel more efficient.
9. Side Effects and When to Seek Care
No comparison of GLP-1 providers is complete without addressing side effects, because the medication experience often matters as much as the monthly price. Across GLP-1 treatment, the most common side effects are typically gastrointestinal. Patients often report nausea, vomiting, diarrhea, constipation, and reduced appetite, especially when a dose is first started or increased. Those effects are often most noticeable during dose escalation, which is one reason onboarding quality and follow-up support matter.
Calibrate’s live review-page profile supports a more structured screening approach. The program’s intake and monitoring model are designed for a year-long metabolic reset, and the article already reflects that Calibrate uses a more thorough intake process that helps gate for higher-risk histories, including conditions such as pancreatitis and eating disorders. That does not eliminate side effects, but it does mean the platform is built around more up-front clinical filtering before medication is advanced.
Mochi Health takes a more access-focused approach, but it still includes meaningful review steps. The article already establishes a 14-screen intake plus a live video visit, giving the prescribing clinician a real-time chance to review history, discuss symptoms, and decide whether brand-name or compounded treatment is appropriate. That live encounter matters because side-effect risk is not just about the medication itself; it is also about dosing pace, prior GI sensitivity, hydration, and comorbid conditions.
For either provider, patients should contact the prescribing clinician if symptoms are persistent, worsening, or interfering with nutrition and hydration. Seek urgent medical evaluation for severe abdominal pain, repeated vomiting, or inability to keep fluids down. Those symptoms can signal a problem that needs more than routine messaging. The goal is not to create fear; it is to match the convenience of telehealth with clear escalation rules if a patient is struggling.
10. Cost Over a Year: What the Numbers Mean
Monthly price is only part of the decision. Many patients stay on GLP-1 therapy for months, not weeks, so an annual planning view is more useful than comparing teaser rates alone.
For Calibrate, the verified recurring number in this article is the $199/month membership. Over 12 months, that equals about $2,388 per year in program fees. That annual figure includes the program structure already described in the body: lab testing, dietitian access, 1:1 video coaching, and the year-long metabolic reset framework. The major variable is medication cost, which is separate and depends on insurance approval and pharmacy fulfillment. For a patient whose insurance covers a brand-name GLP-1, the membership can function as the main predictable recurring cost. For a patient without coverage, total annual spend would be higher because medication is additional, but the live review page does not publish a universal self-pay brand-drug figure, so it should not be guessed.
Mochi Health is easier to model because the live review page publishes clearer all-in numbers for compounded options. The standard membership is $79/month, with the $39 figure representing the separate 1-month plan tier in the intake walkthrough. When that is paired with $99/month compounded semaglutide, the standard all-in figure is $178/month, or about $2,136 per year as a planning figure. When paired with $199/month compounded tirzepatide, the all-in figure is $278/month, or about $3,336 per year.
These numbers are useful because they reveal the tradeoff directly. Calibrate’s recurring program fee alone is higher than Mochi’s all-in semaglutide path, but Calibrate includes labs and a more structured support model. Mochi’s semaglutide track is less expensive on an annual basis, while its tirzepatide track rises above Calibrate’s membership-only cost but still remains more straightforward for self-pay budgeting because the price is published. Treat all of these as planning figures, not guarantees. Insurance coverage, pharmacy route, and treatment changes can materially change the real total.
11. What to Ask Before Enrolling
Before enrolling with either provider, it helps to ask questions that map directly to the care model and pricing structure rather than relying on headlines alone.
For Calibrate, start with the membership itself. Ask exactly what the $199/month covers across the full year and how the year-long program is structured from onboarding through follow-up. Because medication is separate, ask how drug cost is determined if insurance approves the prescription versus if you must pay out of pocket. Confirm how often coaching sessions occur, how dietitian access is used in practice, and what the year-long commitment means if you want to cancel early. Since lab testing is included, also ask how labs are scheduled, what happens if follow-up testing is needed, and whether there are any out-of-network scenarios to plan for.
For Mochi Health, focus on the all-in pricing details and what is or is not bundled. Ask whether the $39 1-month plan tier differs from the standard $79/month membership and what it includes. Then confirm what the $178 all-in semaglutide and $278 all-in tirzepatide figures include and exclude, such as shipping, follow-up visits, or any separate service charges. Because Mochi offers compounded medication without naming its pharmacy or offering a certificate of analysis, ask which compounding pharmacy dispenses the medication in your state and whether a batch Certificate of Analysis can be shared before purchase or shipment. Finally, ask about cancellation terms, how refills are handled, and what happens if you want to switch between brand-name and compounded options later.
These questions do not change the verified scores or pricing in this article. They simply help translate published review-page data into practical buying decisions, which is what a good comparison should do.
FAQ
Q: Does Mochi Health include labs like Calibrate does?
A: No. Mochi Health does not include lab testing in its membership. Calibrate includes lab testing in its $199/month program, while Mochi’s model centers on membership, live video provider visits, and separate medication pricing.
Q: Can I switch from Calibrate to Mochi?
A: Yes. Some patients start with Calibrate for a structured, insurance-dependent brand-name program and later move to Mochi Health if they want a lower-cost option with compounded semaglutide or compounded tirzepatide pricing.
Q: Does Calibrate offer compounded semaglutide in 2026?
A: No. As of August 27, 2026, Calibrate remains a brand-only program. If you want compounded options, Mochi Health or Ivim Health are better choices.
Q: What is Mochi Health’s all-in monthly price in 2026?
A: Based on the live review page, Mochi’s all-in monthly price is $178 for compounded semaglutide and $278 for compounded tirzepatide, combining membership with medication pricing.
Q: Is Mochi Health LegitScript certified?
A: Mochi Health’s own pages (read 7, 8 and 13 October 2026) make no claim to LegitScript certification. LegitScript’s directory is behind a captcha, so we have not checked it.
Corrected 8 October 2026. An earlier version of this comparison said Mochi Health provides a certificate of analysis (CoA) and showed a graphic stating that all of its compounded medications were CoA-verified. That was our error, copied from our Mochi review: Mochi’s site does not offer one.
Corrected 9 October 2026. We removed 3 generated images from this article. Generated images on this site no longer show certifications, organisations, products, prices or figures unless the specific claim has been checked.
Corrected 13 October 2026. This article said Mochi Health claims LegitScript certification. Mochi’s own pages (read 7, 8 and 13 October 2026) make no such claim, so that has been removed. The claim came from our earlier Mochi review.
Corrected 14 October 2026: this article previously gave Better Business Bureau ratings for providers it compares, taken from our April 2026 research. We kept no record of where those ratings came from, so they have been removed.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any medication.
Keep exploring our GLP-1 resources:
